ATE93864T1 - Peptide. - Google Patents
Peptide.Info
- Publication number
- ATE93864T1 ATE93864T1 AT88306696T AT88306696T ATE93864T1 AT E93864 T1 ATE93864 T1 AT E93864T1 AT 88306696 T AT88306696 T AT 88306696T AT 88306696 T AT88306696 T AT 88306696T AT E93864 T1 ATE93864 T1 AT E93864T1
- Authority
- AT
- Austria
- Prior art keywords
- residue
- methylamino
- amino
- methyl
- group
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 125000002015 acyclic group Chemical group 0.000 abstract 5
- XJODGRWDFZVTKW-LURJTMIESA-N (2s)-4-methyl-2-(methylamino)pentanoic acid Chemical group CN[C@H](C(O)=O)CC(C)C XJODGRWDFZVTKW-LURJTMIESA-N 0.000 abstract 4
- -1 amino, methylamino, mercapto Chemical class 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000001931 aliphatic group Chemical group 0.000 abstract 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229930182912 cyclosporin Natural products 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
- 229930105110 Cyclosporin A Natural products 0.000 abstract 1
- 108010036949 Cyclosporine Proteins 0.000 abstract 1
- 108010036941 Cyclosporins Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical group CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 abstract 1
- AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical group CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- IADUEWIQBXOCDZ-UHFFFAOYSA-N azetidine-2-carboxylic acid Chemical compound OC(=O)C1CCN1 IADUEWIQBXOCDZ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 229960001265 ciclosporin Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- HXEACLLIILLPRG-UHFFFAOYSA-N pipecolic acid Chemical compound OC(=O)C1CCCCN1 HXEACLLIILLPRG-UHFFFAOYSA-N 0.000 abstract 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical group C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878717299A GB8717299D0 (en) | 1987-07-22 | 1987-07-22 | Peptides |
| EP88306696A EP0300784B1 (de) | 1987-07-22 | 1988-07-21 | Peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE93864T1 true ATE93864T1 (de) | 1993-09-15 |
Family
ID=10621085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88306696T ATE93864T1 (de) | 1987-07-22 | 1988-07-21 | Peptide. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4997648A (de) |
| EP (1) | EP0300784B1 (de) |
| JP (1) | JPH01151598A (de) |
| AT (1) | ATE93864T1 (de) |
| DE (1) | DE3883658T2 (de) |
| GB (2) | GB8717299D0 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2217319A (en) * | 1988-04-19 | 1989-10-25 | Synpharm Ltd | Racemic and optically active fatty amino acids, their homo- abd hetero-oligomers and conjugates, the process of their production, their pharmaceutical composi |
| GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5362629A (en) * | 1991-08-05 | 1994-11-08 | President And Fellows Of Harvard College | Detection of immunosuppressants |
| AU750245B2 (en) | 1997-10-08 | 2002-07-11 | Aurinia Phamaceuticals Inc. | Deuterated cyclosporine analogs and their use as immunomodulating agents |
| US20030220234A1 (en) * | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| JP2003056266A (ja) * | 2001-08-15 | 2003-02-26 | Kawajun Co Ltd | 固定車輪付き折り畳み脚立 |
| MXPA04003625A (es) * | 2001-10-19 | 2004-12-02 | Sotechnika Inc | Sintesis de analogos de ciclosporina. |
| KR20110111321A (ko) | 2009-01-30 | 2011-10-10 | 이난타 파마슈티칼스, 인코포레이티드 | C형 간염을 예방하거나 치료하기 위한 사이클로스포린 유사체 |
| US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
| US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
| WO2012145427A1 (en) | 2011-04-18 | 2012-10-26 | The Trustees Of Columbia University In The City Of New York | Methods to treat cancer using cyclosporine and cyclosporine derivatives |
| ES2657930T3 (es) | 2011-09-28 | 2018-03-07 | Nosopharm | Nuevos derivados de péptidos como antibióticos |
| WO2014085623A1 (en) | 2012-11-28 | 2014-06-05 | Enanta Pharmaceuticals, Inc. | Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues |
| JP2016538317A (ja) | 2013-08-26 | 2016-12-08 | エナンタ ファーマシューティカルズ インコーポレイテッド | C型肝炎を防止または治療するための新規シクロスポリン類似体 |
| US9669095B2 (en) | 2014-11-03 | 2017-06-06 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues for preventing or treating hepatitis C infection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH614931A5 (de) * | 1975-11-04 | 1979-12-28 | Sandoz Ag | |
| US4117118A (en) * | 1976-04-09 | 1978-09-26 | Sandoz Ltd. | Organic compounds |
| US4075194A (en) * | 1976-12-09 | 1978-02-21 | Yeda Research And Development Co., Ltd. | Novel synthetic undecapeptide and clinical assay |
| GB8303994D0 (en) * | 1983-02-14 | 1983-03-16 | Council Of Governors Of United | Antigenic materials |
-
1987
- 1987-07-22 GB GB878717299A patent/GB8717299D0/en active Pending
-
1988
- 1988-07-21 US US07/222,530 patent/US4997648A/en not_active Expired - Fee Related
- 1988-07-21 DE DE88306696T patent/DE3883658T2/de not_active Expired - Fee Related
- 1988-07-21 EP EP88306696A patent/EP0300784B1/de not_active Expired - Lifetime
- 1988-07-21 AT AT88306696T patent/ATE93864T1/de not_active IP Right Cessation
- 1988-07-21 GB GB8817433A patent/GB2207433B/en not_active Expired - Lifetime
- 1988-07-22 JP JP63184460A patent/JPH01151598A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2207433A (en) | 1989-02-01 |
| DE3883658D1 (de) | 1993-10-07 |
| US4997648A (en) | 1991-03-05 |
| JPH01151598A (ja) | 1989-06-14 |
| GB8817433D0 (en) | 1988-08-24 |
| EP0300784A3 (en) | 1990-06-13 |
| EP0300784A2 (de) | 1989-01-25 |
| GB2207433B (en) | 1990-10-10 |
| DE3883658T2 (de) | 1994-01-05 |
| GB8717299D0 (en) | 1987-08-26 |
| EP0300784B1 (de) | 1993-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3883658D1 (de) | Peptide. | |
| DE3885959D1 (de) | Cyclosporine. | |
| HUP9802603A2 (hu) | Lipofil peptid hormonszármazékok | |
| CA2097192A1 (en) | Bombesin antagonists | |
| DE69832984D1 (de) | DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN | |
| HUP9802372A2 (hu) | Szomatosztatin gyűrűs peptid analógjai | |
| DE69429176D1 (en) | Protegrine | |
| DE60144561D1 (de) | N- und/oder c-terminal mit kurzen geladenen peptidsequenzen modifizierte peptide | |
| ATE127476T1 (de) | Lhrh-analoge. | |
| AU551892B2 (en) | Gnrh antagonists | |
| EP0297456A3 (de) | Immunsuppressive Peptide | |
| ATE47880T1 (de) | Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung. | |
| GB1489326A (en) | Pharmaceutically active polypeptides | |
| CA2086243A1 (en) | Anticoagulant peptides | |
| GB992957A (en) | New decapeptides and their manufacture | |
| AU2002212623A1 (en) | Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit | |
| KR870007206A (ko) | 폴리펩타이드 화합물 | |
| ES416516A1 (es) | Un procedimiento para la preparacion de nonapeptidos. | |
| RU96118282A (ru) | Пептиды для ингибирования высвобождения пепсина | |
| NO931745L (no) | Stabiliserte, sterkt virkende grf-analoger | |
| HUP9904615A2 (hu) | Polipeptid-átmenetifém-sók és eljárás polipeptid HIV-gátló hatásosságának fokozására | |
| ATE17585T1 (de) | Peptide. | |
| GB1524319A (en) | Polypeptide | |
| ES447686A1 (es) | Procedimiento para la preparacion de tripeptidos derivados de la l-prolina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |